사업소개

혁신적 신약개발을 통해 인류의 행복을 추구합니다

연구개발

R&D pipeline

Research / Pre-Clinical

Clinical Development

Registration / Post-Launch

Lifecycle
Management

SKP-0120
Subcutaneous immunoglobulin 20%

SKP-0110
Intravenous immunoglobulin 10%

SKP-0100
Intravenous immunoglobulin 5%

SKP-0130
Albumin 5, 20%

SKP-0140
Haemophilia A

New Product
Development

SKP-0150
Haemophilia B

SKP-0160
Hemostasis

SKP-0170
Anticoagulant

SKP-0180
Haemophilia A

상단으로 이동